Cobicistat + Elvitegravir + Emtricitabine + Tenofovir + Tenofovir Disoproxil

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Cobicistat cobicistat
Elvitegravir elvitegravir
Emtricitabine emtricitabine
Tenofovir tenofovir
Tenofovir Disoproxil tenofovir-disoproxil

Brands with this exact combination

Brand	Composition & strength	Manufacturer
StribildAU CA CZ ES EU GB LV MX US	tablet ×4 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Disoproxil 245 mg tablet ×4 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Disoproxil 300 mg unknown ×2 Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Disoproxil tablet ×2 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir 245 mg Other 1 compositions	Gilead Sciences Ireland UC, Carrigtohill

Brand

Composition & strength

Manufacturer

StribildAU CA CZ ES EU GB LV MX US

tablet ×4 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Disoproxil 245 mg
tablet ×4 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Disoproxil 300 mg
unknown ×2 Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Disoproxil
tablet ×2 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir 245 mg

Other 1 compositions

Gilead Sciences Ireland UC, Carrigtohill

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.